Renal duplex sonographic evaluation of type 2 diabetic patients

Journal of Ultrasound in Medicine

Volumn 32, Issue 6, 2013, Pages 1033-1040

  Mancini, Marcello ^a,b   Masulli, Maria ^a   Liuzzi, Raffaele ^a   Mainenti, Pier Paolo ^a   Ragucci, Monica ^b   Maurea, Simone ^a   Riccardi, Gabriele ^a   Vaccaro, Olga ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b IRCCS SDN   (Italy)

Author keywords

Diabetes; Diabetic nephropathy; Proteinuria; Renal hypertrophy; Resistive index

Indexed keywords

DISEASES; HEMODYNAMICS; MEDICAL PROBLEMS; PATHOLOGY;

DIABETIC NEPHROPATHY; GLOMERULAR FILTRATION RATE; NON-DIABETIC CONTROL; PROTEINURIA; RENAL ARTERY STENOSIS; RENAL HYPERTROPHY; RESISTIVE INDEX; SEGMENTAL ARTERIES;

ULTRASONOGRAPHY;

ADULT; AGED; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DOPPLER ECHOGRAPHY; ECHOGRAPHY; EPIDEMIOLOGY; FEMALE; HUMAN; INCIDENCE; ITALY; KIDNEY; MALE; MIDDLE AGED; REPRODUCIBILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS AND NUMERICAL DATA; ARTICLE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; KIDNEY HYPERTROPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA; RESISTIVE INDEX; STATISTICS;

ADULT; AGED; CAUSALITY; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; INCIDENCE; ITALY; KIDNEY; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

DIABETES; DIABETIC NEPHROPATHY; PROTEINURIA; RENAL HYPERTROPHY; RESISTIVE INDEX;

EID: 84878926540     PISSN: 02784297     EISSN: 15509613     Source Type: Journal    
DOI: 10.7863/ultra.32.6.1033     Document Type: Article

References (54)

1. Molitch ME, DeFronzo RA, Franz MJ, et al; American Diabetes Association. Nephropathy in diabetes. Diabetes Care2004; 7(suppl 1) S79-S83.
2. Bakris GL, Williams M, Dworkin L, et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000; 36:646-661.
3. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 2005; 28:164-176.
4. Mogensen CE, Keane WF, Bennett PH, et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995; 346: 1080-1084.
5. Ruggenenti P, Fassi A, Ilieva AP, et al. Preventing microalbuminuria in type 2 diabetes. N Engl J Med 2004; 351:1941-1951.
6. Krumme B, Blum U, Schwertfeger E, et al. Diagnosis of renovascular disease by intra- and extrarenal Doppler scanning. Kidney Int 1996; 50:1288-1292.
7. Pape L, Offner G, Ehrich JH. Renal arterial resistance index. N Engl J Med 2003; 349:1573-1574.
8. Radermacher J, Mengel M, Ellis S, et al. The renal arterial resistance index and renal allograft survival. N Engl J Med 2003; 349:115-124.
9. Zierler RE, Bergelin RO, Isaacson JA, Strandness DE Jr. Natural history of atherosclerotic renal artery stenosis: a prospective study with duplex ultrasonography. J Vasc Surg 1994; 19:250-258.
10. Masulli M, Mancini M, Liuzzi R, et al. Measurement of the intrarenal arterial resistance index for the identification and prediction of diabetic nephropathy. Nutrition, metabolism, and cardiovascular diseases. Nutr Metab Cardiovasc Dis 2009; 19:358-364.
11. Radermacher J, Ellis S, Haller H. Renal resistance index and progression of renal disease. Hypertension 2002; 39:699-703.
12. Bak M, Thomsen K, Christiansen T, Flyvbjerg A. Renal enlargement precedes renal hyperfiltration in early experimental diabetes in rats. J Am Soc Nephrol 2000; 11:1287-1292.
13. Cortes P, Dumler F, Goldman J, Levin NW. Relationship between renal function and metabolic alterations in early streptozocin-induced diabetes in rats. Diabetes 1987; 36:80-87.
14. Cortes P, Levin NW, Dumler F, Rubenstein AH, Verghese CP, Venkatachalam KK. Uridine triphosphate and RNA synthesis during diabetesinduced renal growth. Am J Physiol 1980; 238:E349-E357.
15. Hostetter TH. Hypertrophy and hyperfunction of the diabetic kidney. J Clin Invest 2001; 107:161-162.
16. Hostetter TH, Troy JL, Brenner BM. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 1981; 19:410-415.
17. Mogensen CE, Andersen MJ. Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 1973; 22:706-712.
18. Seyer-Hansen K. Renal hypertrophy in experimental diabetes: some functional aspects. J Diabet Complications 1987; 1:7-10.
19. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Technical Rep Ser 2000; 894:i-xii, 1-253.
20. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(suppl 1):S1-266.
21. Gabir MM, Hanson RL, Dabelea D, et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 2000; 23:1108-1112.
22. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals, part 1: blood pressure measurement in humans. A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension2005; 45:142-161.
23. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252.
24. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2003; 26(suppl 1):S33-S50.
25. Bartrum RJ Jr, Smith EH, D'Orsi CJ, Dantono J. The ultrasonic determination of renal transplant volume. J Clin Ultrasound 1974; 2:281-285.
26. Hricak H, Lieto RP. Sonographic determination of renal volume. Radiology 1983; 148: 311-312.
27. Verbraecken J, Van de Heyning P, De Backer W, Van Gaal L. Body surface area in normal-weight, overweight, and obese adults: a comparison study. Metabolism 2006; 55:515-524.
28. DuBois D, DuBois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17:863-871.
29. Hoffmann U, Edwards JM, Carter S, et al. Role of duplex scanning for the detection of atherosclerotic renal artery disease. Kidney Int 1991; 39:1232- 1239.
30. Olin JW, Piedmonte MR, Young JR, DeAnna S, Grubb M, Childs MB. The utility of duplex ultrasound scanning of the renal arteries for diagnosing significant renal artery stenosis. Ann Intern Med 1995; 122:833- 838.
31. Taylor DC, Kettler MD, Moneta GL, et al. Duplex ultrasound scanning in the diagnosis of renal artery stenosis: a prospective evaluation. J Vasc Surg 1988; 7:363-369.
32. Mancini M, Daniele S, Raffio T, et al. Intra and interobserver variability of renal allograft ultrasound volume and resistive index measurements. Radiol Med 2005; 109:385-394.
33. Caramori ML, Gross JL, Pecis M, de Azevedo MJ. Glomerular filtration rate, urinary albumin excretion rate, and blood pressure changes in normoalbuminuric normotensive type 1 diabetic patients: an 8-year followup study. Diabetes Care 1999; 22:1512-1516.
34. Ruggenenti P, Porrini EL, Gaspari F, et al. Glomerular hyperfiltration and renal disease progression in type 2 diabetes. Diabetes Care2012; 35:2061-2068.
35. Seyer-Hansen K. Renal hypertrophy in streptozotocin-diabetic rats. Clin Sci Mol Med Suppl 1976; 51:551-555.
36. Seyer-Hansen K. Renal hypertrophy in experimental diabetes: relation to severity of diabetes. Diabetologia 1977; 13:141-143.
37. Zerbini G, Bonfanti R, Meschi F, et al. Persistent renal hypertrophy and faster decline of glomerular filtration rate precede the development of microalbuminuria in type 1 diabetes. Diabetes 2006; 55:2620-2625.
38. de Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes.J Am Soc Nephrol2001; 12:993-1000.
39. Yamamoto Y, Maeshima Y, Kitayama H, et al. Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy. Diabetes 2004; 53:1831-1840.
40. Frauchiger B, Zierler R, Bergelin RO, Isaacson JA, Strandness DE Jr. Prognostic significance of intrarenal resistance indices in patients with renal artery interventions: a preliminary duplex sonographic study. Cardiovasc Surg 1996; 4:324-330.
41. Bude RO, Rubin JM. Relationship between the resistive index and vascular compliance and resistance. Radiology 1999; 211:411-417.
42. Platt JF, Ellis JH, Rubin JM, DiPietro MA, Sedman AB. Intrarenal arterial Doppler sonography in patients with nonobstructive renal disease: correlation of resistive index with biopsy findings. AJR Am J Roentgenol 1990; 154:1223-1227.
43. Aikimbaev KS, Canataroglu A, Ozbek S, Usal A. Renal vascular resistance in progressive systemic sclerosis: evaluation with duplex Doppler ultrasound. Angiology 2001; 52:697-701.
44. Patriquin HB, O'Regan S, Robitaille P, Paltiel H. Hemolytic-uremic syndrome: intrarenal arterial Doppler patterns as a useful guide to therapy. Radiology 1989; 172:625-628.
45. Platt JF, Marn CS, Baliga PK, Ellis JH, Rubin JM, Merion RM. Renal dysfunction in hepatic disease: early identification with renal duplex Doppler US in patients who undergo liver transplantation. Radiology 1992; 183:801-806.
46. Platt JF, Rubin JM, Ellis JH. Lupus nephritis: predictive value of conventional and Doppler US and comparison with serologic and biopsy parameters. Radiology 1997; 203:82-86.
47. Platt JF, Rubin JM, Ellis JH. Diabetic nephropathy: evaluation with renal duplex Doppler US. Radiology 1994; 190:343-346.
48. Taniwaki H, Nishizawa Y, Kawagishi T, et al. Decrease in glomerular filtration rate in Japanese patients with type 2 diabetes is linked to atherosclerosis. Diabetes Care 1998; 21:1848-1855.
49. Kadziela J, Witkowski A, Januszewicz A, et al. Assessment of renal artery stenosis using both resting pressures ratio and fractional flow reserve: relationship to angiography and ultrasonography. Blood Press 2011; 20:211-217.
50. Lee HY, Grant EG. Sonography in renovascular hypertension. J Ultrasound Med 2002; 21:431-441.
51. Li JC, Yuan Y, Qin W, et al. Evaluation of the tardus-parvus pattern in patients with atherosclerotic and nonatherosclerotic renal artery stenosis. J Ultrasound Med 2007; 26:419-426.
52. Zabala L, Ullah S, Pierce CD, et al. Transesophageal Doppler measurement of renal arterial blood flow velocities and indices in children. Anesth Analg 2012; 114:1277-1284.
53. Forsblom CM, Groop PH, Ekstrand A, et al. Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM. Diabetes Care 1998; 21:1932-1938.
54. Murussi M, Baglio P, Gross JL, Silveiro SP. Risk factors for microalbuminuria and macroalbuminuria in type 2 diabetic patients: a 9-year follow-up study. Diabetes Care 2002; 25:1101-1103.